DK1558616T3 - Meso-substituerede porphyriner - Google Patents

Meso-substituerede porphyriner

Info

Publication number: DK1558616T3
Authority: DK; Denmark
Prior art keywords: meso; substituted porphyrins; porphyrins; substituted; general formula
Prior art date: 2002-10-21

Application number

DK03769429T

Other languages

English (en)

Other versions

DK1558616T4 (da

Inventor

Francesca Giuntini

Giacomo Chiti

Daniele Nistri

Lia Fantetti

Valentina Paschetta

Annalisa Cocchi

Gabrio Roncucci

Donata Dei

Original Assignee

Molteni & C

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-21

Filing date

2003-10-21

Publication date

2008-06-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32104761&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1558616(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-10-21 Application filed by Molteni & C filed Critical Molteni & C

2008-06-23 Publication of DK1558616T3 publication Critical patent/DK1558616T3/da

2011-12-12 Application granted granted Critical

2011-12-12 Publication of DK1558616T4 publication Critical patent/DK1558616T4/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/30—Fuel from waste, e.g. synthetic alcohol or diesel

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Urology & Nephrology (AREA)
Biochemistry (AREA)
Vascular Medicine (AREA)
Virology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Hematology (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Medicinal Preparation (AREA)
Radiation-Therapy Devices (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

DK03769429.6T 2002-10-21 2003-10-21 Meso-substituerede porphyriner DK1558616T4 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT000200A ITFI20020200A1 (it)	2002-10-21	2002-10-21	Porfirine meso-sostituite.
PCT/EP2003/011642 WO2004035590A2 (en)	2002-10-21	2003-10-21	Meso-substituted porphyrins

Publications (2)

Publication Number	Publication Date
DK1558616T3 true DK1558616T3 (da)	2008-06-23
DK1558616T4 DK1558616T4 (da)	2011-12-12

Family

ID=32104761

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK03769429.6T DK1558616T4 (da)	2002-10-21	2003-10-21	Meso-substituerede porphyriner

Country Status (17)

Country	Link
US (2)	US7947674B2 (da)
EP (1)	EP1558616B2 (da)
JP (1)	JP4751068B2 (da)
CN (1)	CN1714091A (da)
AT (1)	ATE387450T1 (da)
AU (1)	AU2003278118B8 (da)
CA (1)	CA2503223C (da)
CY (1)	CY1107963T1 (da)
DE (1)	DE60319406T3 (da)
DK (1)	DK1558616T4 (da)
ES (1)	ES2301840T5 (da)
IL (1)	IL168104A0 (da)
IT (1)	ITFI20020200A1 (da)
PT (1)	PT1558616E (da)
SI (1)	SI1558616T2 (da)
WO (1)	WO2004035590A2 (da)
ZA (1)	ZA200504102B (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1356813B1 (en) *	2002-04-25	2005-07-20	L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA' DI ESERCIZIO SOCIETA' PER AZIONI	Antibacterial compositions comprising metal phthalocyanine analogues
ITFI20020200A1 (it) *	2002-10-21	2004-04-22	Molteni & C Dei Flii Alitti S P A Societa L	Porfirine meso-sostituite.
GB2397067B (en) *	2002-12-23	2005-05-11	Destiny Pharma Ltd	Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
CA2528347A1 (en) *	2003-06-06	2005-01-06	Eukarion, Inc.	Orally bioavailable low molecular weight metalloporphyrins as antioxidants
GB2415372A (en) *	2004-06-23	2005-12-28	Destiny Pharma Ltd	Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
GB2415373A (en) *	2004-06-23	2005-12-28	Destiny Pharma Ltd	Porphyrins for sonodynamic therapy
GB0526474D0 (en) *	2005-12-24	2006-02-08	Destiny Pharma Ltd	Novel process
WO2008108937A1 (en)	2007-03-05	2008-09-12	North Carolina State University	Method of making porphyrins
EP3459955B1 (en) *	2008-09-18	2022-11-02	biolitec Unternehmensberatungs II AG	Novel method and application of unsymmetrically meso-substituted porphyrins and chlorins for pdt
CN102180881A (zh) *	2011-03-25	2011-09-14	西北农林科技大学	3,8,13-三碘-5,10,15-三烷基三聚吲哚的制备方法
EP2759546B1 (en) *	2011-09-21	2018-03-21	National University Corporation Okayama University	Metalloporphyrin complex, manufacturing process therefor and its use as carbon dioxide fixation catalyst, as well as process for manufacturing cyclic carbonate
CN102499924B (zh) *	2011-11-23	2013-07-24	中国医学科学院生物医学工程研究所	二乙撑三胺五乙酸或乙二胺四乙酸或胺三乙酸修饰卟啉的用途
US9364537B2 (en) *	2014-08-22	2016-06-14	University Of Dayton	Transition metal porphyrin complexes and methods of treatment using same
CN104725388B (zh) *	2015-03-25	2017-03-15	南京林业大学	一种meso位芳胺基单取代卟啉衍生物及其制备方法
KR20180100570A (ko) *	2016-01-13	2018-09-11	제이에스알 가부시끼가이샤	감방사선성 수지 조성물, 레지스트 패턴 형성 방법, 산 확산 제어제 및 화합물
CN106146522A (zh) *	2016-06-27	2016-11-23	桂林理工大学	苯并菲癸烷氧基桥连十二烷氧基苯基卟啉金属Ni配合物的合成方法
CN106118689A (zh) *	2016-06-27	2016-11-16	桂林理工大学	苯并菲己烷氧基桥连异辛烷氧基苯基卟啉二元化合物盘状液晶材料的合成方法
CN106117221A (zh) *	2016-06-27	2016-11-16	桂林理工大学	苯并菲己烷氧基桥连异辛烷氧基苯基卟啉金属Ni配合物的合成方法
CN106118688A (zh) *	2016-06-27	2016-11-16	桂林理工大学	苯并菲癸烷氧基桥连异辛烷氧基苯基卟啉二元化合物盘状液晶材料的合成方法
CN106117225A (zh) *	2016-06-27	2016-11-16	桂林理工大学	苯并菲癸烷氧基桥连异辛烷氧基苯基卟啉金属Zn配合物的合成方法
CN106117223A (zh) *	2016-06-27	2016-11-16	桂林理工大学	苯并菲十二烷氧基桥连异辛烷氧基苯基卟啉金属Ni配合物的合成方法
CN106047369A (zh) *	2016-06-27	2016-10-26	桂林理工大学	苯并菲己烷氧基桥连十二烷氧基苯基卟啉二元化合物盘状液晶材料的合成方法
CN106117220A (zh) *	2016-06-27	2016-11-16	桂林理工大学	苯并菲十二烷氧基桥连异辛烷氧基苯基卟啉金属Zn配合物的合成方法
CN106117222A (zh) *	2016-06-27	2016-11-16	桂林理工大学	苯并菲十二烷氧基桥连异辛烷氧基苯基卟啉二元化合物盘状液晶材料合成方法
CN105924448A (zh) *	2016-06-27	2016-09-07	桂林理工大学	苯并菲己烷氧基桥连十二烷氧基苯基卟啉金属Ni配合物的合成方法
CN106117224A (zh) *	2016-06-27	2016-11-16	桂林理工大学	苯并菲十二烷氧基桥连十二烷氧基苯基卟啉二元化合物盘状液晶材料的合成方法
CN105949208A (zh) *	2016-06-27	2016-09-21	桂林理工大学	苯并菲己烷氧基桥连十二烷氧基苯基卟啉金属Zn配合物的合成方法
CN106046010A (zh) *	2016-06-27	2016-10-26	桂林理工大学	5‑对苯甲酸基‑10, 15, 20‑三对异辛烷氧基苯基卟啉的合成方法
CN106146523A (zh) *	2016-06-27	2016-11-23	桂林理工大学	苯并菲十二烷氧基桥连十二烷氧基苯基卟啉金属Ni配合物的合成方法
CN106117227A (zh) *	2016-06-27	2016-11-16	桂林理工大学	苯并菲癸烷氧基桥连十二烷氧基苯基卟啉二元化合物盘状液晶材料的合成方法
CN106117228A (zh) *	2016-06-27	2016-11-16	桂林理工大学	苯并菲癸烷氧基桥连异辛烷氧基苯基卟啉金属Ni配合物的合成方法
CN106588941A (zh) *	2016-12-08	2017-04-26	桂林理工大学	苯并菲十二烷氧基桥连四苯基卟啉三元化合物盘状液晶材料的合成方法
CN106749284A (zh) *	2016-12-08	2017-05-31	桂林理工大学	苯并菲十二烷氧基桥连异辛烷氧基苯基卟啉三元化合物盘状液晶材料的合成方法
CN106749285A (zh) *	2016-12-08	2017-05-31	桂林理工大学	苯并菲己氧基桥连异辛烷氧基苯基卟啉三元化合物盘状液晶材料的合成方法
CN106588942A (zh) *	2016-12-08	2017-04-26	桂林理工大学	并菲癸氧基桥连四苯基卟啉三元化合物盘状液晶材料的合成方法
CN106588940A (zh) *	2016-12-08	2017-04-26	桂林理工大学	苯并菲癸氧基桥连异辛烷氧基苯基卟啉三元化合物盘状液晶材料的合成方法
CN106967075A (zh) *	2017-04-22	2017-07-21	桂林理工大学	苯并菲癸烷氧基桥连甲氧羰基苯基卟啉金属Zn配合物的合成方法
CN107089987A (zh) *	2017-04-22	2017-08-25	桂林理工大学	苯并菲己烷氧基桥连异辛烷氧基苯基卟啉金属Zn配合物的合成方法
CN107011349A (zh) *	2017-04-22	2017-08-04	桂林理工大学	苯并菲癸烷氧基桥连异辛烷氧基苯基卟啉金属Zn配合物的合成方法
CN106905334A (zh) *	2017-04-22	2017-06-30	桂林理工大学	苯并菲十二烷氧基桥连甲氧羰基苯基卟啉金属Zn配合物的合成方法
CN107043381A (zh) *	2017-04-22	2017-08-15	桂林理工大学	苯并菲十二烷氧基桥连异辛烷氧基苯基卟啉金属Zn配合物的合成方法
US10722582B2 (en) *	2018-04-12	2020-07-28	Purdue Research Foundation	Targeted antimicrobial photodynamic therapy
CN110354770B (zh) *	2019-07-23	2022-10-04	中国石油大学(华东)	一种人工光合微反应器及制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8805849D0 (en) *	1988-03-11	1988-04-13	Efamol Holdings	Porphyrins & cancer treatment
FR2632187B1 (fr) *	1988-06-02	1990-09-14	Centre Nat Rech Scient	Derives de metalloporphyrines, leur preparation, leur application en therapeutique et leur utilisation pour la preparation de molecules hybrides
IL122451A0 (en) *	1995-06-07	1998-06-15	Univ Duke	Oxidant scavengers
WO1998033503A1 (en) *	1997-02-05	1998-08-06	Board Of Regents, The University Of Texas System	Porphyrin compounds as telomerase inhibitors
IT1294325B1 (it)	1997-08-14	1999-03-24	Molteni L E C Dei Fratelli Ali	Zinco-ftalocianine e relativi coniugati, preparazione e uso nella terapia fotodinamica e come diagnostici
CA2341507C (en) *	1998-08-28	2011-05-24	William Guy Love	Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them
ATE259814T1 (de) *	2000-06-15	2004-03-15	Molteni & C	Substituierte metallphthalocyaninen, ihre herstellung und verwendung
FR2812637B1 (fr) *	2000-08-01	2002-10-25	Anulm Ass Nantaise Pour L Util	Nouveaux composes derives de dihydroporphyrine et leurs applications
CA2441386C (en)	2001-03-21	2010-12-21	L. Molteni E C. Dei Fratelli Alitti Societa Di Esercizio S.P.A.	Metal substituted non centrosymmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
ITFI20020200A1 (it)	2002-10-21	2004-04-22	Molteni & C Dei Flii Alitti S P A Societa L	Porfirine meso-sostituite.
GB2397067B (en)	2002-12-23	2005-05-11	Destiny Pharma Ltd	Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation

2002
- 2002-10-21 IT IT000200A patent/ITFI20020200A1/it unknown
2003
- 2003-10-21 CA CA2503223A patent/CA2503223C/en not_active Expired - Fee Related
- 2003-10-21 CN CNA2003801017372A patent/CN1714091A/zh active Pending
- 2003-10-21 US US10/532,278 patent/US7947674B2/en not_active Expired - Fee Related
- 2003-10-21 AU AU2003278118A patent/AU2003278118B8/en not_active Ceased
- 2003-10-21 DK DK03769429.6T patent/DK1558616T4/da active
- 2003-10-21 SI SI200331212T patent/SI1558616T2/sl unknown
- 2003-10-21 DE DE60319406T patent/DE60319406T3/de not_active Expired - Lifetime
- 2003-10-21 JP JP2004544280A patent/JP4751068B2/ja not_active Expired - Fee Related
- 2003-10-21 PT PT03769429T patent/PT1558616E/pt unknown
- 2003-10-21 AT AT03769429T patent/ATE387450T1/de active
- 2003-10-21 WO PCT/EP2003/011642 patent/WO2004035590A2/en not_active Ceased
- 2003-10-21 ES ES03769429T patent/ES2301840T5/es not_active Expired - Lifetime
- 2003-10-21 EP EP03769429A patent/EP1558616B2/en not_active Expired - Lifetime
2005
- 2005-04-18 IL IL168104A patent/IL168104A0/en not_active IP Right Cessation
- 2005-05-20 ZA ZA200504102A patent/ZA200504102B/en unknown
2008
- 2008-05-26 CY CY20081100540T patent/CY1107963T1/el unknown
2011
- 2011-01-14 US US13/007,345 patent/US8288528B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ES2301840T3 (es)	2008-07-01
CA2503223C (en)	2010-11-23
EP1558616B2 (en)	2011-08-24
US8288528B2 (en)	2012-10-16
CA2503223A1 (en)	2004-04-29
IL168104A0 (en)	2009-02-11
DE60319406T3 (de)	2012-02-23
IT1333697B (da)	2006-05-09
EP1558616A2 (en)	2005-08-03
ZA200504102B (en)	2006-07-26
AU2003278118A1 (en)	2004-05-04
US7947674B2 (en)	2011-05-24
WO2004035590A3 (en)	2004-07-29
PT1558616E (pt)	2008-05-12
JP2006512301A (ja)	2006-04-13
US20060040914A1 (en)	2006-02-23
AU2003278118B8 (en)	2009-09-17
ITFI20020200A1 (it)	2004-04-22
SI1558616T1 (sl)	2008-08-31
WO2004035590A2 (en)	2004-04-29
CN1714091A (zh)	2005-12-28
CY1107963T1 (el)	2013-09-04
AU2003278118B2 (en)	2009-05-21
US20110112464A1 (en)	2011-05-12
EP1558616B1 (en)	2008-02-27
JP4751068B2 (ja)	2011-08-17
DK1558616T4 (da)	2011-12-12
ES2301840T5 (es)	2012-01-13
DE60319406T2 (de)	2009-03-19
ATE387450T1 (de)	2008-03-15
DE60319406D1 (de)	2008-04-10
SI1558616T2 (sl)	2011-12-30

Publication	Publication Date	Title
DK1558616T4 (da)	2011-12-12	Meso-substituerede porphyriner
DE602004026113D1 (de)	2010-04-29	Glp-1-verbindungen
WO2006093891A3 (en)	2009-05-14	Photosensitizers for targeted photodynamic therapy
NO20044995L (no)	2005-01-18	Heterosykliske forbindelser
CR6577A (es)	2003-12-05	Inhibidores triciclicos de poli(adp-ribosa) polimerasas
ATE302775T1 (de)	2005-09-15	Carbolinderivate
WO2002096366A3 (en)	2003-03-20	Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
ATE484508T1 (de)	2010-10-15	Furylverbindungen
ATE524476T1 (de)	2011-09-15	Pyrazolopyrimidine als modulatoren von caseinkinase ii (ck2)
CY1109722T1 (el)	2014-04-09	Ενδιαμεσες ενωσεις για την παρασκευη της trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,73oxepino[4,5-c]pyrrole
EA200501253A1 (ru)	2006-02-24	Производные пиразоло[1,5-a][1,3,5]триазина в качестве лигандов каннабиноидных рецепторов
DE60333746D1 (de)	2010-09-23	Thienylverbindungen
GB2442915B (en)	2009-12-16	Perylenequinone derivatives and uses thereof
PE20030061A1 (es)	2003-02-08	1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
BRPI0513149A (pt)	2008-04-29	uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituìdas no tratamento de náuseas e vÈmito
SE0301650D0 (sv)	2003-06-04	Novel compounds
ATE447960T1 (de)	2009-11-15	Antivirale verwendung von borinsäurekomplexen
WO2003028628A3 (en)	2004-01-08	Photosensitizing carbamate derivatives
ATE368649T1 (de)	2007-08-15	Cyanoguanidin prodrugs
ATE337320T1 (de)	2006-09-15	Indolderivate als pde5-inhibitoren
ATE248840T1 (de)	2003-09-15	Porphyrine und verwandte verbindungen
EA200702136A1 (ru)	2008-04-28	Композиции станнсопорфина и их применение
BR0308976A (pt)	2005-01-11	Terapia combinada contra tumores compreendendo derivados de acriloil distamicina substituìda e radioterapia